Annual Short Term Debt
$10.01 M
+$9.34 M+1407.08%
31 December 2023
Summary:
CymaBay Therapeutics annual short term debt is currently $10.01 million, with the most recent change of +$9.34 million (+1407.08%) on 31 December 2023. During the last 3 years, it has risen by +$9.44 million (+1664.90%).CBAY Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$10.01 M
+$9.80 M+4757.77%
31 December 2023
Summary:
CymaBay Therapeutics quarterly short term debt is currently $10.01 million, with the most recent change of +$9.80 million (+4757.77%) on 31 December 2023.CBAY Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +1664.9% | +1664.9% |
| 5 y5 years | +2358.7% | +2358.7% |
CBAY Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -27.2% | at high |
CymaBay Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $10.01 M(+1407.1%) | $10.01 M(+4757.8%) |
| Sept 2023 | - | $206.00 K(-44.9%) |
| June 2023 | - | $374.00 K(-30.4%) |
| Mar 2023 | - | $537.00 K(-19.1%) |
| Dec 2022 | $664.00 K(+17.1%) | $664.00 K(+3.9%) |
| Sept 2022 | - | $639.00 K(+4.1%) |
| June 2022 | - | $614.00 K(+4.1%) |
| Mar 2022 | - | $590.00 K(+4.1%) |
| Dec 2021 | $567.00 K(+17.6%) | $567.00 K(+4.0%) |
| Sept 2021 | - | $545.00 K(+4.2%) |
| June 2021 | - | $523.00 K(+4.2%) |
| Mar 2021 | - | $502.00 K(+4.1%) |
| Dec 2020 | $482.00 K(+18.4%) | $482.00 K(+4.3%) |
| Sept 2020 | - | $462.00 K(+4.3%) |
| June 2020 | - | $443.00 K(+4.5%) |
| Mar 2020 | - | $424.00 K(+4.2%) |
| Dec 2019 | $407.00 K | $407.00 K(+4.6%) |
| Sept 2019 | - | $389.00 K(+4.3%) |
| June 2019 | - | $373.00 K(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $357.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2018 | - | $3.22 M(+3.6%) |
| Dec 2017 | $3.11 M(+15.1%) | $3.11 M(+3.6%) |
| Sept 2017 | - | $3.00 M(+3.6%) |
| June 2017 | - | $2.90 M(+3.6%) |
| Mar 2017 | - | $2.80 M(+3.6%) |
| Dec 2016 | $2.70 M(+430.5%) | $2.70 M(+3.6%) |
| Sept 2016 | - | $2.61 M(+27.7%) |
| June 2016 | - | $2.04 M(+61.7%) |
| Mar 2016 | - | $1.26 M(+147.9%) |
| Dec 2015 | $509.00 K(-62.4%) | $509.00 K(-64.9%) |
| June 2015 | - | $1.45 M(+3.3%) |
| Mar 2015 | - | $1.40 M(+3.5%) |
| Dec 2014 | $1.35 M(+3465.8%) | $1.35 M(+13.6%) |
| Sept 2014 | - | $1.19 M(+50.1%) |
| June 2014 | - | $795.00 K(+93.9%) |
| Mar 2014 | - | $410.00 K(+978.9%) |
| Dec 2013 | $38.00 K(-99.7%) | $38.00 K |
| Dec 2012 | $13.74 M | - |
FAQ
- What is CymaBay Therapeutics annual short term debt?
- What is the all time high annual short term debt for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for CymaBay Therapeutics?
What is CymaBay Therapeutics annual short term debt?
The current annual short term debt of CBAY is $10.01 M
What is the all time high annual short term debt for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual short term debt is $13.74 M
What is CymaBay Therapeutics quarterly short term debt?
The current quarterly short term debt of CBAY is $10.01 M
What is the all time high quarterly short term debt for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly short term debt is $10.01 M